Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit

Critical Care Medicine

Volumn 36, Issue 7, 2008, Pages 2008-2013

  Palmer, Lucy B ^a   Smaldone, Gerald C ^a   Chen, John J ^b   Baram, Daniel ^a   Duan, Tao ^b   Monteforte, Melinda ^b   Varela, Marie ^b   Tempone, Ann K ^c   O'Riordan, Thomas ^a   Daroowalla, Feroza ^a   Richman, Paul ^a  

^a Pulmonary Section   (United States)

^b University Hospital

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacterial resistance; Endotracheal tube; Nebulizer; Pneumonia; Systemic antibiotics; Ventilator associated tracheobronchitis; Weaning

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; PLACEBO; SODIUM CHLORIDE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AEROSOL; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; GRAM STAINING; HUMAN; INFORMED CONSENT; INTENSIVE CARE UNIT; INTUBATION; LEUKOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PERSISTENT INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SUPPURATION; SURVIVAL; TRACHEOBRONCHITIS; UNIVERSITY HOSPITAL; VENTILATOR; VENTILATOR ASSISTED TRACHEOBRONCHITIS; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS; BRONCHITIS; CLASSIFICATION; CROSS INFECTION; ENDOTRACHEAL INTUBATION; INHALATIONAL DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; TRACHEA DISEASE;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHITIS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; TRACHEAL DISEASES; VENTILATOR WEANING;

EID: 47249146963     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31817c0f9e     Document Type: Article

References (25)

1. Palmer LB, Smaldone GC, Simon SR, et al: Aerosolized antibiotics in mechanically ventilated patients: Delivery and response. Crit Care Med 1998; 26:31-39
2. Palmer LB, Smaldone GC, Simon S, et al: Tracheal aspirates in long-term mechanically ventilated patients. A human model of gram-negative infection and airway inflammation. Chest 1995; 108:1326-1332
3. O'Riordan TG, Palmer LB, Smaldone GC: Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 1994; 149: 214-219
4. Miller DD, Amin MM, Palmer LB, et al: Aerosol delivery and modern mechanical ventilation: In vitro/in vivo evaluation. Am J Respir Crit Care Med 2003; 168:1205-1209
5. Nseir S, Di Pompeo C, Pronnier P, et al: Nosocomial tracheobronchitis in mechanically ventilated patients: Incidence, aetiology and outcome. Eur Respir J 2002; 20:1483-1489
6. Nseir S, Di Pompeo C, Soubrier S, et al: Outcomes of COPD patients with nosocomial tracheobronchitis. Infection 2004; 32: 210-216
7. Nseir S, Di Pompeo C, Soubrier S, et al: Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: A case-control study. Crit Care 2005; 9:R238-245
8. Torres A, Valencia M: Does ventilator-associated tracheobronchitis need antibiotic treatment? Crit Care 2005; 9:255-256
9. Center for Disease Control: NNIS Pneumonia Diagnosis. CDC 2002, XV-7
10. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162(2 Pt 1):505-511
11. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
12. Smaldone GC, Fuhrer J, Steigbigel RT, et al: Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1991; 143(4 Pt 1):727-737
13. Kollef MH, Morrow LE, Niederman MS, et al: Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-1218
14. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22
15. ATS: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. A J Respir Crit Care Med 2005; 171: 388-416
16. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290: 2588-2598
17. Dennesen PJ, van der Ven AJ, Kessels AG, et al: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375
18. Le Conte P, Potel G, Clementi E, et al: [Administration of tobramycin aerosols in patients with nosocomial pneumonia: A preliminary study]. Presse Med 2000; 29:76-78
19. Rathgeber J, Zielmann S, Panzer C, et al: [Prevention of pneumonia by endotracheal micronebulization of tobramycin]. Anasthe-siol Intensivmed Notfallmed Schmerzther 1993; 28:23-29
20. Wood GC, Boucher BA, Croce MA, et al: Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 2002; 22:972-982
21. Hamer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by mul-tidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000; 162:328-330
22. Brown RB, Kruse JA, Counts GW, et al: Double-blind study of endotracheal tobramy-cin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group. Antimicrob Agents Chemother 1990; 34:269-272
23. Rouby JJ, Poete P, Martin de Lassale E, et al: Prevention of gram-negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study. Intensive Care Med 1994; 20:187-192
24. Feeley TW, Du Moulin GC, Hedley-Whyte J, et al: Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975; 293:471-475
25. Klick JM, du Moulin GC, Hedley-Whyte J, et al: Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients. J Clin Invest 1975; 55:514-519